Skip to main navigation Skip to search Skip to main content

Dab2, a negative regulator of DC immunogenicity, is an attractive molecular target for DC-based immunotherapy

  • Md Selim Ahmed
  • , Se Eun Byeon
  • , Yideul Jeong
  • , Mohammad Alam Miah
  • , Md Salahuddin
  • , Yoon Lee
  • , Sung Soo Park
  • , Yong Soo Bae*
    • *Corresponding author for this work

    Research output: Contribution to journal › Article › peer-review

    35   Link opens in a new tab Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Dab2, a negative regulator of DC immunogenicity, is an attractive molecular target for DC-based immunotherapy'. Together they form a unique fingerprint.
    Sort by

    Keyphrases

    Immunology and Microbiology